Alzheimer's disease & dementia

LSL60101 compound reduces neuroinflammation and improves cognition

The LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies against Alzheimer's disease. This is stated in the recent studies by the Research Group ...

Oncology & Cancer

Novel class of drugs may help treat deadly lymphoma

A new class of drugs that inhibits a 'master switch' involved in the vast majority of cases of mantle cell lymphoma (MCL), a fatal subtype of non-Hodgkin's lymphoma, has been discovered by researchers at Mount Sinai.

Medical research

New killing mechanism discovered in 'game-changing' antibiotic

Scientists at the University of Liverpool and University of Utrecht have taken another step forward on their quest to develop a viable drug based on teixobactin—a new class of potent natural antibiotic capable of killing ...

page 3 from 7